Boston Scientific
698 hedge funds and large institutions have $49.2B invested in Boston Scientific in 2018 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 235 increasing their positions, 239 reducing their positions, and 56 closing their positions.
132% more call options, than puts
Call options by funds: $232M | Put options by funds: $100M
61% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 56
20% more funds holding in top 10
Funds holding in top 10: 15 → 18 (+3)
18% more capital invested
Capital invested by funds: $41.7B → $49.2B (+$7.52B)
4% more funds holding
Funds holding: 671 → 698 (+27)
0.2% less ownership
Funds ownership: 92.63% → 92.42% (-0.2%)
2% less repeat investments, than reductions
Existing positions increased: 235 | Existing positions reduced: 239
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$308M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$301M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$179M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$110M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$105M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$626M |
| 2 |
Goldman Sachs
New York
|
-$169M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$127M |
| 4 |
GA
Geller Advisors
New York
|
-$90.2M |
| 5 |
Two Sigma Advisers
New York
|
-$89.2M |
BSX Hedge Fund Activity: Q3 2018 in Review
698 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2018, worth a combined $49.2B — up 18% from $41.7B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new BSX positions and 56 closed out — a net gain of 34 holders — while 235 added to existing stakes and 239 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $308M. The largest seller was Capital World Investors, cutting an estimated $626M.
- 698 institutional investors held Boston Scientific (BSX) as of Q3 2018, up from 671 in Q2 2018.
- Funds reported $49.2B of Boston Scientific stock for Q3 2018, up 18% quarter-over-quarter.
- 90 funds opened new Boston Scientific positions in Q3 2018 and 56 closed out, a net change of +34 holders.
- The largest Boston Scientific buyer in Q3 2018 was Capital Research Global Investors, an estimated $308M added.
- The largest Boston Scientific seller in Q3 2018 was Capital World Investors, an estimated $626M sold.
Based on aggregated 13F filings for Q3 2018.